Market News AIOpen the app

SENS stock news · Senseonics

Stories about Senseonics (SENS) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for SENS

Follow Senseonics (SENS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SENS
Free on the App Store and Google Play, or on the web.
  1. Nov 16, 2026, 5:35 PM ET · Market

    Beta Bionics has started using its iLet system with the Eversense 365 glucose monitor to help diabetes patients.

    Good for SENS

    Senseonics' Eversense 365 is now part of Beta Bionics' launched iLet system, where its readings help automate insulin decisions. The story gives no sales or patient-use figures, but the launch gives the sensor a new commercial use.

  2. Nov 16, 2026, 5:33 PM ET · Product

    Senseonics and Beta Bionics are launching the Eversense 365 system to help manage diabetes better.

    Good for SENS

    Senseonics launched its year-long glucose monitor with Beta Bionics' insulin system, meeting their fourth-quarter 2026 target. This puts its sensor in a combined product and supports Senseonics.

  3. Oct 12, 2026, 7:22 AM ET · Results

    Senseonics Holdings shares the full details of its earnings call for the second quarter of 2026.

    Good for SENS

    Senseonics reported about 120% second-quarter sales growth, raised its 2026 sales and gross margin targets, and raised over $100 million. The update points to stronger business prospects.